December 1, 2010
The Sally Edelman-Harry Gardner Cancer Research Foundation, a Hilton-based grassroots organization dedicated to finding cures for cancer, has awarded $50,000 grant to a pair of scientists working to better understand the mechanisms of pancreatic cancer.
HuckyLand, Ph.D., chair of Biomedical Genetics and scientific director of Wilmot Cancer Center, and Aram Hezel, M.D., assistant professor of Medicine and gastrointestinal oncologist, received the funding to study a new potential target in pancreatic cancer that Land recently identified. Hezel will build upon Land's laboratory findings to determine whether the new target is effective in treating the disease.
Each year, about 43,000 Americans are diagnosed with pancreatic cancer, a deadly disease with few warning signs or symptoms until it has spread to other organs. Survival rates are poor. Pancreatic cancer has received significant attention in recent years after actor Patrick Swayze succumbed to the disease.
Any advances that we can make to improve the treatment of pancreatic cancer are a major step forward,says Richard I. Fisher, M.D., director of the Wilmot Cancer Center.
It's wonderful to see this Foundation continue to partner with us to find cures.
November 11, 2010
Dirk Bohmann, Ph.D., an accomplished molecular biologist and geneticist, today received the 2010 Davey Memorial Award for outstanding cancer research.
July 15, 2010
Two large federal grants received this summer will allow researchers at the James P. Wilmot Cancer Center to continue their work into stem cells that give rise to cancer.
May 25, 2010
University of Rochester Medical Center scientists discovered a defect in cellular pathways that provides a new explanation for the earliest stages of abnormal skull development in newborns, known as craniosynostosis.
May 24, 2010
The University of Rochester Medical Center has received a $3.3 million grant from the Empire State Stem Cell Board for the construction of a new facility that will enable scientists to produce human stem cells suitable for testing new therapies.
May 7, 2010
Today, the department of Biomedical Genetics 22nd Annual Genetics Day was highlighted by the 8th Annual Fred Sherman Lecture. Dr. Fred Sherman, Professor Emeritus of Biochemistry & Biophysics has been honored for his contributions to Genetics and Yeast Genetics for the past nine years with a lecture named after him. The NIH has funded Fred for a remarkable 45 years, during which time he has published over 280 papers, with more on the way.
In 1970, Fred initiated the famous yeast course at Cold Spring Harbor, which has trained scores of today's leading investigators. He served as an instructor in this course for 17 years. Fred's many landmark contributions to several fields of molecular biology were recognized by his election to the National Academy of Sciences in 1985.Genetics Day is an annual event, including a poster session and plenary lectures, that brings together the University genetics community defined in its broadest sense. This year, Dr. Stuart L. Schreiber, Director of Chemical Biology at and Founding Member of the Broad Institute of Harvard and MIT, gave the Sherman Lecture entilted, Relating the genetic features of cancers to drug efficacies using small-molecule probes.
January 19, 2010
Scientists trying to understand how cancer cells invade healthy tissue have used the fruit fly's metamorphosis from maggot to flying insect as a guide to identify a key molecular signal that may be involved in both processes.
For more information and details on how to apply please visit the Office for Graduate Education and Postdoctoral Affairs.